Dr. Ram Sasisekharan
Alfred H. Caspary Professor of Biological Engineering and Health Sciences & Technology
Massachusetts Institute of technology
Cambridge, MA

Awarded in April 2017

Dr. Sasisekharan has been a professor of biological engineering at MIT since 1996, and has served as the director of the Harvard-MIT Division of Health Sciences & Technology from 2008-2012. The Sasisekharan lab employs multidisciplinary strategies to develop and integrate orthogonal analytical technologies to further research into complex biopharmaceuticals. The lab originated its efforts with GAGs (such as heparin) to develop analytical and enzymatic tools with the pertinent and defined substrate-product profiles required to understand their structure-function relationships. Timely development and characterization of therapeutic mAb to treat infectious diseases and cancer are currently of paramount interest to his lab. Dr. Sasisekharan has been recognized by numerous accolades and awards, and his ideas and concepts have been the founding basis of many biotechnology companies. (press release)

Dr. Dwight R. Stoll
Associate Professor of Analytical Chemistry
Co-chair of the Chemistry Department
Gustavus Adolphus College
Saint Peter, Minnesota

Awarded in March 2017

Dr. Stoll is widely recognized for his efforts and contributions to analytical chemistry and separation sciences. His active research projects include the development of rapid multidimensional liquid chromatography for targeted and untargeted analysis in complex matrices and optimization of isocratic and gradient elution HPLC. He has pioneered the development of 2D-HPLC and its applications in BioPharma.

Dr. Stoll has received numerous awards and recognitions including the John B. Phillips Award for contributions to multidimensional gas chromatography, the LCGC’s Emerging Leader in Chromatography Award. In 2014 he was named to The Analytical Scientist’s list of ‘Top 40 Under 40’ analytical scientists and received the American Chemical Society Division of Analytical Chemistry Award for Young Investigators in Separation Science in 2015. In 2016 he received the Palmer Award from the Minnesota Chromatography Forum and the Gustavus Faculty Scholarly Achievement. Earlier this year he received the Eastern Analytical Symposium Young Investigator Award. (press release)

Shane A. Snyder 博士
Professor - Chemical and Environmental Engineering
Co-Director of the Arizona Laboratory for Emerging Contaminants (ALEC) and the Water & Energy Sustainable Technology (WEST) Center
University of Arizona
Tucson, AZ

獲獎日期：2016 年 10 月

Snyder 博士以其在水污染物分析與管理方面的工作和貢獻獲得了廣泛的認可。他的研究集中在使用各種最先進的分析儀器，對已知及未知環(huán)境污染物的鑒定和定量分析方法進行研究和應用。而且，他的工作包括使用體外生物檢定法分析水污染物的毒性效應。此外，Snyder 博士的工程研究集中在開發(fā)水處理技術(shù)，以最大限度降低能耗并最大程度改善水質(zhì)。

Snyder 博士是國際雜志 Chemosphere 的主編，其因在應對全球水資源挑戰(zhàn)方面的杰出工作于 2016 年被評選為國際水協(xié)會研究員。（新聞稿）

Rohit Bhargava 博士
Founder Professor of Engineering and Chemistry | Director, Cancer Center at Illinois
Depts. of Bioengineering, Electrical & Computer Sciences, Mechanical Science & Engineering, Chemical & Biomolecular Engineering and Chemistry
University of Illinois at Urbana-Champaign
Urbana, IL

獲獎日期：2016 年 10 月

Bhargava 博士因其在紅外光譜成像領(lǐng)域所做出的先驅(qū)工作而廣受贊譽。他的工作包括提出有關(guān)紅外成像的新穎理論和建模，以及研究其在光譜分析方面的應用。還包括展開儀器開發(fā)和計算方法方面的研究，以提取高保真信息以推動具有挑戰(zhàn)性的研究。他的工作集中在生物醫(yī)學科學的光譜成像應用，特別是癌癥生物學和案例研究的臨床應用。在他的實驗室中開發(fā)的儀器已被用作新的表征工具，通過化學成像來定義癌癥。（新聞稿）

Scott W. Lowe 博士
Chair, Cancer Biology & Genetics Program, Sloan Kettering Institute
Chair, Geoffrey Beene Cancer Research Center
Memorial Sloan Kettering Cancer Center
New York, NY

獲獎日期：2016 年 8 月

Lowe 博士的研究為我們理解 p53、APC 以及 PTEN 等數(shù)種關(guān)鍵腫瘤抑制基因做出了貢獻。同樣，他成功建立了無數(shù)遺傳篩選和動物模型，在新型目標藥物的鑒定和表征，以及確定對新療法可能比較敏感的癌細胞的易感性方面發(fā)揮了重要作用。其中某些篩選和動物模型已經(jīng)在廣泛使用 shRNAi 文庫。最近，Lowe 博士采用 CRISPR/Cas 9 進一步發(fā)掘了這項技術(shù)的優(yōu)勢，以增進我們對癌癥的理解和管理。（新聞稿）

Peter Robinson 博士
Professor of Computational Biology
The Jackson Laboratory for Genomic Medicine
Farmington, CT

獲獎日期：2016 年 2 月

Robinson 博士以開發(fā)人類表型本體（人類疾病中遇到的表型異常的標準化詞匯）而聞名，并且他創(chuàng)建了用于鑒定各種新的疾病基因的方法。Robinson 博士曾就讀于哥倫比亞大學數(shù)學與計算機科學專業(yè)和賓夕法尼亞大學醫(yī)學專業(yè)。他在柏林自由大學和大學附屬夏里特 (Charité) 醫(yī)院完成了兒科醫(yī)師實習。（新聞稿）

Shilin Chen 博士?
Director, Institute of Chinese Materia Medica,
China Academy of Chinese Medical Sciences
Beijing, China

獲獎日期：2016 年 2 月

陳博士是北京中國中醫(yī)科學院中藥研究所的負責人。他主要從事天然產(chǎn)物的藥物化學領(lǐng)域的研究工作，該研究涉及到中藥活性成分鑒定及其作用機制的確定，得到了學術(shù)界的高度認可。研究包括但不限于青蒿素等抗瘧系列藥物。同樣，陳博士率先采用基因組方法（如 NGS 測序和 DNA 條形碼）進行藥用植物物種的鑒定。（新聞稿）

Jeffrey I. Gordon 博士?
The Dr. Robert J. Glaser Distinguished University Professor and
Director of the Center for Genome Sciences & Systems Biology
Washington University School of Medicine
St. Louis, MO

獲獎日期：2015 年 10 月

Gordon 博士是全球公認的微生物組研究領(lǐng)域的先驅(qū)和領(lǐng)導者。他的成就，包括極具影響力的 2005 年度 NHGRI 白皮書，題目為“擴展我們對自身的認識：人類腸道微生物倡議 (HGMI)”，并因此獲得了 2007 年創(chuàng)立的 NIH“用于醫(yī)學研究的人類微生物組計劃路線圖”基金。Gordon 博士的研究方向主要為研究人類與胃腸道中的數(shù)萬億共生菌之間的互利關(guān)系。他的研究采用了無菌小鼠作為宿主模型，并采用宏基因組學、代謝組學、微生物學、生物化學和營養(yǎng)科學等手段研究人類腸道微生物組成及它們對人類健康和發(fā)育的影響。他和他的團隊特別關(guān)注與營養(yǎng)不良、肥胖以及神經(jīng)和免疫調(diào)節(jié)及發(fā)育有關(guān)的領(lǐng)域。（新聞稿）

Lawrence J. Lesko 博士?
Department of Pharmaceutics
College of Pharmacy
University of Florida,
Orlando, Florida

獲獎日期：2015 年 3 月

Lesko 博士是位于諾娜湖的佛羅里達大學藥學院藥物計量學與系統(tǒng)藥理學中心主任。在加入佛羅里達大學 (UF) 之前，Lesko 博士曾在美國食品藥品監(jiān)督管理局 (FDA) 藥物評估和研究中心擔任臨床藥理學辦公室主任近二十年。他曾是 FDA 的醫(yī)療政策協(xié)調(diào)委員會臨床藥理學協(xié)調(diào)分會的主席，撰寫或與人合著了眾多的行業(yè)指南，并啟動了 FDA 的自愿基因組數(shù)據(jù)提交計劃和藥物安全機制計劃。（新聞稿）

Arturo A. Keller 博士
Department of Environmental Biogeochemistry
Bren School
University of California, Santa Barbara
Santa Barbara, CA

Awarded March 2015

Arturo Keller 博士是加州大學圣塔芭芭拉分校納米技術(shù)環(huán)境影響中心的負責人。他憑借天然水和土壤中納米顆粒的吸收、積累與生物轉(zhuǎn)化研究獲得了國際認可。他研究的一項重點是分析納米顆粒以便將其安全、可持續(xù)地引入農(nóng)業(yè)產(chǎn)業(yè)。（新聞稿）

Jules Griffin 博士
Department of Biochemistry
University of Cambridge
United Kingdom

獲獎日期：2014 年 9 月

Jules Griffin 博士是倫敦帝國學院名譽教授， 國王學院院士，劍橋大學生物化學系高級講師。他還領(lǐng)導了 MRC 脂質(zhì)分析和信號傳導計劃。他專注于研究利用高分辨率質(zhì)譜儀測量生物體液和組織提取物中的脂類以更好地了解 2 型糖尿病和肥胖癥（通常也被統(tǒng)稱為代謝綜合征）的病因和后果，并開發(fā)了用于存儲和處理這些實驗產(chǎn)生的大量數(shù)據(jù)的計算機軟件工具。（新聞稿）

Carlos Cordon-Cardo 博士
The Irene Heinz Given and John LaPorte Given Professor
and Chair of Pathology for the Mount Sinai Health System
Dept. of Pathology
The Mount Sinai Hospital
New York, NY

Awarded: August 2014

Cordon-Cardo 博士是一位杰出的臨床醫(yī)生和研究人員，他開創(chuàng)性地研究了實驗病理學和分子腫瘤學，并得到了國際上的認可。他的研究集中于分析人類癌癥中腫瘤抑制基因的多藥耐藥和改變，以及人類癌癥干細胞的分離和表征。他還為腫瘤分子病理學學科的發(fā)展和實施作出了貢獻，并幫助創(chuàng)建了“系統(tǒng)病理學平臺”。（新聞稿）

Carolyn Mountford 博士
Centre for MR in Health
School of Health Sciences
Faculty of Health and Medicine
University of Newcastle
Australia

Awarded: April 2013

Mountford 博士是澳大利亞紐卡斯爾大學健康科學學院和哈佛醫(yī)學院的放射學教授。她是紐卡斯爾大學臨床研究核磁共振中心的負責人，同時也是波士頓布列根和婦女醫(yī)院臨床光譜中心的負責人。Mountford 博士的代表性貢獻是創(chuàng)新性地將核磁共振 (NMR) 光譜技術(shù)用于癌癥研究。（新聞稿）

John A. McLean 博士
Stevenson Professor
Department of Chemistry
Vanderbilt University
Nashville, TN

Awarded: March 2014

在范德堡大學的化學系，McLean 教授和他的同事致力于結(jié)構(gòu)質(zhì)譜儀的構(gòu)想、設計和建造，特別是針對系統(tǒng)生物學、合成生物學、化學生物學以及納米技術(shù)中的復雜樣品的研究。他的研究小組將這些策略應用到最前沿轉(zhuǎn)化研究領(lǐng)域，該研究領(lǐng)域主要涵蓋藥物發(fā)現(xiàn)、個體化醫(yī)療以及“人類芯片”合成生物學平臺。（新聞稿）

Joshua D. Rabinowitz 博士
Professor of Chemistry and Integrative Genomics
Princeton University
Princeton, NJ

Awarded: October 2013

Rabinowitz 博士為代謝組學領(lǐng)域做出了開創(chuàng)性的概念和方法學上的貢獻。這些貢獻包括同位素標記、樣品前處理、數(shù)據(jù)分析和適用于液質(zhì)聯(lián)用系統(tǒng)數(shù)據(jù)的信息可視化技術(shù)的開發(fā)。（新聞稿）

Paul B. Watkins 博士
Professor of Medicine, Toxicology, and Experimental Therapeutics
Director, Institute for Drug Safety Sciences
The Hamner Institutes for Health Sciences
Research Triangle Park, NC

Awarded: October 2013

Paul B. Watkins 醫(yī)學博士是北卡羅來納大學教堂山分校 (UNC) 的醫(yī)學、毒理學與實驗治療學教授，也是藥物安全科學研究所的主任。Watkins 博士是國際公認的藥物安全方面的專家，具有豐富的藥源性肝臟損傷 (DILI) 研究經(jīng)驗，研究內(nèi)容包括藥物代謝與轉(zhuǎn)運方面的基礎研究、臨床研究、因果關(guān)系評估和法規(guī)事務。（新聞稿）

Junying Yuan 博士
Director of the Interdisciplinary Research Center on Biology
Chinese Academy of Science
Shanghai, China

Awarded: November 2013

Junying Yuan 博士是細胞凋亡研究領(lǐng)域的先驅(qū)和頂尖研究人員。“安捷倫思想領(lǐng)袖獎”將大力支持在中國科學院新成立的生物與化學跨學科研究中心進行的鑒定神經(jīng)退行性疾病的生物標記物的代謝組學和系統(tǒng)生物學研究。（新聞稿）

Guibin Jiang 博士
Director of State Key Laboratory of Environmental Chemistry and Ecotoxicology
Chinese Academy of Sciences
Haidian District,
Beijing, China

Awarded: October 2013

江博士主要致力于分析化學和環(huán)境化學的研究。他系統(tǒng)全面的研究成效顯著，研究包括：持久性有機污染物 (POP) 的分析方法開發(fā)和環(huán)境表征、以及有機金屬化合物的形態(tài)分析，他的研究為中國這類科學領(lǐng)域的改善和國際化做出了重要貢獻。（新聞稿）

Emmanuel Barillot 博士
Director of Bioinformatics and Systems IT
Institut Curie
Paris, France

Awarded: August 2013

Barillot 博士的工作領(lǐng)域是開發(fā)細胞信號通路的數(shù)據(jù)庫以及促進制藥行業(yè)研發(fā)出更高效的癌癥治療方法的可視化工具。（新聞稿）

Hashim Al-Hashimi 博士
J. Lawrence Oncley Collegiate Professor of Chemistry and Biophysics
Dept. of Chemistry and Biophysics
University of Michigan
Ann Arbor, MI

Awarded: March 2013

Hashim Al-Hashimi 博士是一位在結(jié)構(gòu)生物學領(lǐng)域頗具影響力的研究人員。Al-Hashimi 博士和他的團隊在密歇根大學 進行 Hoogsteen 堿基對高級表征方法的開發(fā)，他利用核磁共振光譜對一種與典型的雙螺旋結(jié)構(gòu)不同的罕見 DNA 進行表征。Hoogsteen 堿基對以生物化學家 Karst Hoogsteen 的名字命名，因其不同尋常的結(jié)構(gòu)和生物功能而備受關(guān)注。Al-Hashimi 博士和他的團隊相信通過他們的研究能夠顯著推動 DNA 靶向藥物發(fā)現(xiàn)和其他應用的發(fā)展。（新聞稿）

Ronald DePinho 醫(yī)學博士
President, MD Anderson Cancer Center
University of Texas
Houston, TX

Awarded: December 2012

Ronald A. DePinho 博士，世界著名的腫瘤學家和研究人員，榮獲安捷倫思想領(lǐng)袖獎，此項獎勵將用于表彰他在癌癥早期階段代謝物重編程的研究。他對于癌癥、衰老和與年齡相關(guān)的退行性疾病的基礎及轉(zhuǎn)化研究得到了國際的認可。他是安德森 70 年歷史上唯一一位四次當選的全職主席。（新聞稿）

Robert Gerszten 醫(yī)學博士
Director of Clinical and Translational Research
Institute for Heart, Vascular and Stroke Care
Massachusetts General Hospital
Boston, MA

Awarded: November 2012

Robert E. Gerszten 博士榮獲安捷倫思想領(lǐng)袖獎，以表彰其在心血管及相關(guān)代謝疾病中代謝物生物標記物發(fā)現(xiàn)的研究。Gerszten 博士率先使用蛋白質(zhì)組學和代謝組學方法，通過弗雷明漢心臟隊列研究來鑒定這些疾病的生物標記物。（新聞稿）

Dr. Jens Frisvad
Professor, Department of Systems Biology
Center for Microbial Biotechnology
Technical University of Denmark
Lyngby, Denmark

Awarded: May 2012

Frisvad 教授主要從事真菌研究。其研究方向主要為霉菌的生化多樣性，致力于發(fā)現(xiàn)可用于藥物的新酶和次級代謝產(chǎn)物。此外，他還進行關(guān)于青霉菌和曲霉屬真菌的真菌毒素及霉菌的研究，試圖找到辦法防止食物、室內(nèi)環(huán)境和生物技術(shù)產(chǎn)品中產(chǎn)生毒素。（新聞稿）

Russell Thomas 博士
Senior Investigator
Director, Institute for Chemical Safety Sciences
Director, Center for Genomic Biology and Bioinformatics
Hamner Institutes for Health Sciences

Awarded: December 2011

Russell S. Thomas 博士來自哈姆納健康科學研究院，他被授予安捷倫思想領(lǐng)袖獎。此獎項用于支持其開發(fā)預測藥物導致肝損害的方法。這個獎項包含安捷倫科技基金會提供的經(jīng)費以及安捷倫公司提供的儀器，包括一套 6460 三重四極桿液質(zhì)聯(lián)用系統(tǒng)和一臺安捷倫微陣列芯片掃描儀。Thomas 博士是哈姆納化學安全科學研究院主任。此研究院正致力于應用一種系統(tǒng)生物學方法預測藥物導致的肝損害。（新聞稿）

Chris Evelo 博士
Department Head, Bioinformatics BiGCaT
Maastricht University
Maastricht, Netherlands

Awarded: November 2011

馬斯特里赫特大學生物信息學系的 Chris Evelo 博士榮獲了安捷倫思想領(lǐng)袖獎，以表彰他在開發(fā)用于整合不同類型生物數(shù)據(jù)的軟件中所做出的貢獻。該獎項的目的在于通過推進系統(tǒng)生物學方法的整合來幫助加快疾病研究的突破性進展。Evelo 實驗室?guī)椭_發(fā)了用于構(gòu)建多組學數(shù)據(jù)的社區(qū)策劃平臺 — WikiPathways.org，以及相關(guān)開放式通路分析工具 PathVisio。（新聞稿）

Steven Carr 博士
Senior Scientific Leader, Protein Biochemistry and Proteomics
Broad Institute
Cambridge, MA

Awarded: October 2011

Steven Carr 博士就職于布羅德研究所（隸屬于麻省理工學院和哈佛大學），榮獲安捷倫??思想領(lǐng)袖獎。該獎項將用于表彰 Carrs 在蛋白質(zhì)和多肽分析新技術(shù)開發(fā)研究方向做出的努力，他的研究旨在幫助醫(yī)生診斷疾病，如心血管疾病、乳腺癌和卵巢癌。（新聞稿）

Gerhard Wagner 博士
Department of Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, MA

Awarded: August 2011

Gerhard Wagner 博士就職于哈佛醫(yī)學院生物化學與分子藥理學系，榮獲安捷倫思想領(lǐng)袖獎，該獎項用以表彰他對現(xiàn)代結(jié)構(gòu)生物學工具構(gòu)成嚴峻挑戰(zhàn)的生物相關(guān)系統(tǒng)研究的方法開發(fā)方面所做的努力。Wagner 教授的研究工作將極大提高 NMR 光譜在大型蛋白質(zhì)的分配和結(jié)構(gòu)鑒定方面的影響，NMR 光譜通過現(xiàn)代高場儀器的功能與合適的采集和處理方法相配合進行蛋白質(zhì)研究。 （新聞稿）

Adam Arkin 博士
Director, Synthetic Biology Institute
Dean A. Richard Newton Memorial Professor,
Department of Bioengineering
University of California, Berkeley
Director, Physical Biosciences Division, Lawrence Berkeley National Lab

Awarded: April 2011

Adam Arkin 是 SBI（合成生物學研究所）和勞倫斯伯克利國家實驗室物理生物科學部主任，加州大學伯克利分校生物工程系 Dean A. Richard Newton 紀念教授。他也是微生物壓力和生存虛擬研究所的聯(lián)合主管，聯(lián)合生物能源研究所生物信息學主任，以及 BIOFAB（國際前沿生物技術(shù)開放實驗室）的聯(lián)合主管。他的研究集中于揭示蜂窩網(wǎng)絡和種群的進化設計原則，并將其進行開拓應用。他和同事正通過將比較功能基因組學、細胞動力學的定量測定、蜂窩網(wǎng)絡的生物物理建模以及蜂窩式電路設計結(jié)合起來，開發(fā)一種可促進健康、環(huán)境和生物能源應用的框架。（新聞稿）

Bart Weimer 博士
Professor, Population Health & Reproduction
School of Veterinary Medicine
University of California, Davis

Awarded: January 2011

Weimer 博士的實驗室團隊在獸醫(yī)學院專注于微生物生理和功能的研究。他們通過研究宿主/微生物相互作用，闡釋了益生菌與腸道上皮細胞的競爭性結(jié)合，以及致病菌（例如，沙門氏菌）的移位。通過使用基因組學和功能基因組學基因表達、代謝組學、蛋白質(zhì)組學以及宏基因組學，Weimer 博士的研究計劃考察了基因相互作用以產(chǎn)生特定表型的機制，以及過程中涉及的新陳代謝。

David Botstein 博士
Lewis-Sigler Institute for Integrative Genomics
Princeton University

Awarded: November 2010

Dr. David Botstein, professor and director of the Lewis-Sigler Institute for Integrative Genomics and the Center for Quantitative Biology at Princeton University, received an Agilent Thought Leader award in support of his research in the area of genomics. This award of cash funding and Agilent products to the Lewis-Sigler Institute for Integrative Genomics will allow Dr. Botstein to produce the most complete genomic, proteomic and metabolomic data sets from any eukaryote (organism with cells containing membrane-enclosed structures including nucleus) to date. (press release)

Hailu Kinde 博士，預防獸醫(yī)學碩士，獸醫(yī)學博士
UC Davis School of Veterinary Medicine California Animal Health and Food Safety Laboratory

Awarded: October 2010

Dr. Hailu Kinde, professor at the California Animal Health and Food Safety Laboratory System, received an Agilent Thought Leader award in support of his research in the area of food safety. This award of cash funding and Agilent products to the UC Davis School of Veterinary Medicine will allow Dr. Kinde to focus on the development of a new process that can reduce the time required to identify food-borne pathogens from several days to only a few hours. (press release)

Thomas Hartung 博士
Director for the Center for Alternatives to Animal Testing (CAAT)
Bloomberg School of Public Health
Johns Hopkins University

Awarded: August 2010

Dr. Thomas Hartung received an Agilent Thought Leader award in support of his research on for the use of toxicity pathways to predict developmental neurotoxicity. Through this award of funding from the Agilent Foundation and a company donation of instruments to the Center for Alternatives to Animal Testing (CAAT) at the Johns Hopkins Bloomberg School of Public Health, Dr. Hartung will focus his research on the identification of novel toxicity pathways by combining two promising cell culture models with emerging metabolomics. This work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders. (press release)

James Collins 博士
Professor of Biomedical Engineering
Wyss Institute for Biologically Inspired Engineering

Awarded: July 2010

James Collins 博士正在開發(fā)對生物體（特別是細菌）進行重新編程的創(chuàng)新方法，以便執(zhí)行所需的任務，比如攻擊腫瘤和引導干細胞的發(fā)育。這些編程后的細菌使得藥物更加便宜，燃料更加環(huán)保，同時還能對抗生素耐藥性引起的感染和疾病實現(xiàn)更有效的治療。他是系統(tǒng)生物學、隨機共振、生物動力學和神經(jīng)刺激研究領(lǐng)域的先驅(qū)，他的目標是改善生理和生物系統(tǒng)的功能。（新聞稿）

George Church 博士
Professor of Genetics
Harvard Medical School
Director of the Center for Computational Genetics
Wyss Institute for Biologically Inspired Engineering
Boston, MA

Awarded: July 2010

Dr. George Church is Professor of Genetics at Harvard Medical School and Director of NIH-CEGS and DOE-GTL Genomics Centers. He has pioneered technology innovations early in the development of key fields in chemistry and biomedicine with 10 US Patents granted and several pending. As part of technology transfer to the commercial sector he has served on 22 scientific advisory boards. In 1976, his crystallographic software lead to the first high-resolution folded-RNA structure (a decade before similar structures important for ribozymes, aptamers, and RNAi). (press release)

Don Ingber 博士
Wyss Institute Founding Director
and Core Faculty Member
Platform Leader, Biomimetic Microsystems

Awarded: July 2010

Dr. Ingber is Founding Director of the Wyss Institute and a leader in the emerging field of biologically inspired engineering. He oversees a multifaceted effort to identify the mechanisms that living organisms use to self assemble and to apply these design principles to develop advanced materials and devices. Dr. Ingber was the first researcher to recognize that tensegrity architecture (in which a system stabilizes itself mechanically by balancing local compression with continuous tension) is a fundamental principle in the way living organisms are structured at the nanometer scale. (press release)

Janne Lehtio 博士
Karolinska Institute
Department of Oncology-Pathology
Science for Life Laboratory

Awarded: June 2010

Dr. Janne Lehtio has worked on clinical proteomics both in academia and biotech industry. In 2004, Dr. Lehtio was selected to build mass spectrometry based proteomics at Karolinska University Hospital and continues his proteomics research there. Today, Dr. Lehtio leads a mass-spectrometry-based proteomics group at Karolinska Institutet focusing on quantitative proteomics methods development and cancer proteomics. In recent year his lab has developed several methods for clinical proteomics and currently uses these methods to understand proteome changes related to cancer therapy.

Pauline Rudd 博士
Professor of Glycobiology
University College Dublin
National Institute for Bioprocessing Research and Training (NIBRT)

Awarded: May 2010

Dr. Pauline Rudd received an Agilent Thought Leader award in March 2010 in support of emerging glycomics research through a grant of funding and instruments to the National Institute for Bioprocessing Research and Training (NIBRT) at the University College Dublin in Ireland. The goal of the research is to develop novel approaches to analyze protein glycosylation as part of the characterization process of recombinant protein drugs and to study disease glycan biomarkers using liquid chromatography mass spectrometry. (press release)